Will Aclaris Therapeutics Inc (ACRS) Trail the Rest of the Stocks in the Healthcare Sector?

Aclaris Therapeutics Inc (ACRS) is around the bottom of the Healthcare sector according to InvestorsObserver. ACRS received an overall rating of 9, which means that it scores higher than 9% of stocks. Additionally, Aclaris Therapeutics Inc scored a 19 in the Healthcare sector, ranking it higher than 19% of stocks in that sector.

ACRS has an Overall Score of 9. Find out what this means to you and get the rest of the rankings on ACRS!

See Full ACRS Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 9 would rank higher than 9 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Aclaris Therapeutics Inc Stock Today?

Aclaris Therapeutics Inc (ACRS) stock has fallen -5.14% while the S&P 500 is higher by 0% as of 2:44 PM on Friday, Mar 22. ACRS has fallen -$0.06 from the previous closing price of $1.20 on volume of 287,614 shares. Over the past year the S&P 500 is up 32.75% while ACRS has fallen -86.01%. ACRS lost -$1.27 per share the over the last 12 months. Click Here to get the full Stock Report for Aclaris Therapeutics Inc stock.